Skip to website navigation Skip to article navigation Skip to content

CapEx taxonomy disclosure 

Financial year 2023

  

2023

Sustantial contribution criteria

DNSH criteria
(Does Not Significantly Harm)

    

Economic activities

Code

CapEx (Meuro)

Proportion of CapEx 2023 (%)

Climate change mitigation

Climate change adaptation

Water

Circular economy

Pollution

Biodiversity

Climate change mitigation

Climate change adaptation

Water

Circular economy

Pollution

Biodiversity

Minimum safeguards

Proportion of Taxonomy-aligned (A.1.) or eligible (A.2.) CapEx, year 2022

Category (enabling activity)

Category (transitional activity)

A. Taxonomy eligible activities

                 

A.1. Environmentally sustainable activities (Taxonomy-aligned)

              

Manufacture of other low carbon technologies1

CCM 3,6

50.5

35.0%

Y

N/EL

N/EL

N/EL

N/EL

N/EL

Y

Y

Y

Y

Y

Y

Y

43.9%

E

 

CapEx of environmentally sustainable activities (Taxonomy-aligned) (A.1)

 

50.5

35.0%

35.0%

0%

0%

0%

0%

0%

Y

Y

Y

Y

Y

Y

Y

43.9%

  

Of which enabling

 

50.5

35.0%

35.0%

0%

0%

0%

0%

0%

Y

Y

Y

Y

Y

Y

Y

43.9%

E

 

Of which transitional

 

-

-

-

     

-

-

-

-

-

-

-

-

 

T

A.2. Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities)

          

Manufacture of other low carbon technologies2

CCM 3,6

10.8

7.5%

EL

N/EL

N/EL

N/EL

N/EL

N/EL

       

8.1%

  

CapEx of Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) (A.2)

 

10.8

7.5%

7.5%

0%

0%

0%

0%

0%

       

8.1%

  

A. CapEx of Taxonomy- eligible activities (A.1+A.2)3

 

61.3

42.5%

42.5%

0%

0%

0%

0%

0%

       

52.0%

  

B. Taxonomy non eligible activities

                

CAPEX of Taxonomy non-eligible activities (B)

 

82.9

57.5%

                

Total (A+B)4

 

144.2

100.0%

                

Proportion of CAPEX / Total CAPEX

 

Taxonomy-aligned per objective

Taxonomy-eligible per objective

CCM

35.0%

42.5%

CCA

0%

0%

WTR

0%

0%

CE

0%

0%

PPC

0%

0%

BIO

0%

0%

1

CapEx supporting lactic acid sales for PLA, consisting of a) CapEx related to the existing site in Rayong, Thailand, based on the share of net sales of lactic acid produced at Corbion Rayong in the PLA segment and b) CapEx related to the construction of a new site for the expansion of manufacturing capacity of lactic acid for PLA (CapEx plan). The aligned CapEx (€ 50.5 million) is split in the following categories: property, plant, and equipment (€ 50.2 million) and capitalized right-of-use assets (€ 0.3 million). Of the aligned property, plant, and equipment, € 48.7 million is related to the CapEx Plan. The expected capital expense during the remaining period of the CapEx plan is € 10.4 million and the expected start-up is in the first quarter of 2024.

2

CapEx supporting sales of AlgaPrime DHA. This includes all CapEx at our Orindiúva, Brazil, manufacturing facility.

3

CapEx supporting sales of AlgaPrime DHA and sales of lactic acid in the PLA segment. No double counting because only climate mitigation is considered, and the activities are geographically separated.

4

Reported under the capital expenditure and acquisition of group companies sections of property, plant, and equipment; leases; and intangible fixed assets in the year (see Notes 10, 11, and 12 of the Consolidated statement of financial position).